Cited by 634Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 139 of the 142 references it cites were found in a registry or an index.

Improving cancer immunotherapy through nanotechnology

Goldberg, Michael S.·2019·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

The 2018 Nobel Prize in Physiology or Medicine was awarded to pioneers in the field of cancer immunotherapy, as the utility of leveraging a patient's coordinated and adaptive immune system to fight the patient's unique tumour has now been validated robustly in the clinic. Still, the proportion of patients who respond to immunotherapy remains modest (~15% objective response rate across indications), as tumours have multiple means of immune evasion. The immune system is spatiotemporally controlled, so therapies that influence the immune system should be spatiotemporally controlled as well, in order to maximize the therapeutic index. Nanoparticles and biomaterials enable one to program the location, pharmacokinetics and co-delivery of immunomodulatory compounds, eliciting responses that cannot be achieved upon administration of such compounds in solution. The convergence of cancer immunotherapy, nanotechnology, bioengineering and drug delivery is opportune, as each of these fields has matured independently to the point that it can now be used to complement the others substantively and rationally, rather than modestly and empirically. As a result, unmet needs increasingly can be addressed with deductive intention. This Review explores how nanotechnology and related approaches are being applied to augmenting both endogenous leukocytes and adoptively transferred ones by informing specificity, influencing localization and improving function.

Integrity signals

Registry

Crossref · 10.1038/s41568-019-0186-9

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448

Show all 142 references

Research works printed but not linked: 2

Luteijn, R. et al. SLC19A1 is a cyclic dinucleotide transporter. Preprint at bioRxiv https://www.biorxiv.org/content/10.1101/539767v1 (2019). · DOI
Nature Collection: Nobel Prize in Physiology or Medicine 2018, https://www.nature.com/collections/gqznlfngkz (2018).

Sorted by citations

Items 501–600 of 634

Natural Killer-Based Therapy: A Prospective Thought for Cancer Treatment Related to Diversified Drug Delivery Pathways
Zang, J., Mei, Y., Zhu, S., Yin, S., Feng, N., Ci, T., & Lyu, Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070939 · Cited by 3
Photosensitizer with High Efficiency Generated in Cells via Light‐Induced Self‐Oligomerization of 4,6‐Dibromothieno[3,4‐b]thiophene Compound Entailing a Triphenyl Phosphonium Group
Wang, L., Huang, Y., Yu, Y., Zhong, H., Xiao, H., Zhang, G., & Zhang, D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100896 · Cited by 3
Exploring the therapeutic implications of nanoparticles for liquid tumors: A comprehensive review with special emphasis on green synthesis techniques in the context of Dalton’s lymphoma
Kumar, N., Delu, V., Nain, T., Kumar, A., Pooja, P., & Acharya, A. (2023) · THE SCIENTIFIC TEMPER · doi:10.58414/scientifictemper.2023.14.3.55 · Cited by 3
Evaluation of the anti-breast cancer properties of Origanum majorana aqueous extract green-mediated nanoparticles
Zhao, J., Hu, Y., Zhou, S., Li, W., Song, Z., Fan, Q., Liu, X., Meng, X.-R., Wang, X., & Zhang, H. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.113098 · Cited by 3
Advancements in a Zebrafish Model for Toxicity Assessment of Nanomaterials
Lee, S. L. J., & Lin, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-9116-4_5 · Cited by 4
Nanotherapeutics-induced pyroptosis for targeted cancer therapy: mechanistic insights and translational prospects
Dighe, S., & Jain, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104521 · Cited by 2
Functionalized graphene oxide nanoplatform for synergistic photothermal-immunotherapy via targeted siPD-L1 delivery in triple-negative breast Cancer
Shi, M., Zhu, H., Wang, Y., Guo, Y., Wang, Y., Wang, H., Wang, N., Gong, T., & Guo, R. (2026) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2026.116173 · Cited by 2
Nanobiotechnology for dendritic cell-based cancer immunotherapy
Li, R. H., Yi, W., Qian, X., Hu, S., Shen, H., Yan, D., & Li, Y. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100485 · Cited by 2
Experimental Animal Models to Evaluate the Therapeutic Efficacy of Nanoformulations Against Cancer
Narayan, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_133 · Cited by 2
Advancements in the Utilization of Metal Nanoparticles for Breast Cancer Treatment: An In Vivo Studies Update
Rahdari, M., Hashemi, H., Hashemi, S. M. A., Nadjafi-Semnani, A., Jamalie, S., Sakhaee, M. H., Zabihi, F., Razavi, S. A. S., Khaboushan, M. T., & Ahmadi, G. (2023) · Journal of Lab Animal Research · doi:10.58803/jlar.v2i5.31 · Cited by 2
Nano-based vaccination and their administration routes in cancer immunotherapy
Ahmed, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18770-4.00006-8 · Cited by 2
A review on human cancer and potential role of MXenes in cancer therapy
Rashid, B., Sridewi, N., Anwar, A., Shahabbudin, S., & Mon, A. A. (2024) · E3S Web of Conferences · doi:10.1051/e3sconf/202448803021 · Cited by 2
Immunogenic ferroptosis protects against the development of tumour growth
Saviuk, M. O., Turubanova, V. D., Efimova, Y. V., Mishchenko, T. A., Mishchenko, T. A., Vedunova, M. V., & Krysko, D. V. (2023) · Genes and Cells · doi:10.17816/gc623271 · Cited by 2
Chiral Nanofibers of Camptothecin Trigger Pyroptosis for Enhanced Immunotherapy
Gao, F., Qiu, X., Baddi, S., He, S., Wang, S., Zhao, C., Dou, X., & Feng, C. (2025) · Angewandte Chemie · doi:10.1002/ange.202423446 · Cited by 2
One‐pot synthesis chlorin e6 nano‐precipitation for colorectal cancer treatment Ce6 NPs for colorectal cancer treatment
Miao, Z., Wang, Y., Li, S., Zhang, M., & Xu, M. (2021) · IET Nanobiotechnology · doi:10.1049/nbt2.12065 · Cited by 2
Targeting cancer-associated fibroblasts in immunotherapy
Kim, D., Wu, Y., & Oh, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00007-5 · Cited by 2
Immunotherapy for Breast Cancer
Costa, K. M. N., de Melo, D. F., Soares, I. L. D. S., Damasceno, B. P. G. D. L., & Oshiro, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_224-1 · Cited by 2
Fighting Cancer Using Nanoparticles – Diagnosis, Treatment and Monitoring
Cifrić, S., Spahić, L., Osmanović, D., Imamović, E., & Deumić, A. (2021) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-73909-6_76 · Cited by 2
Functional Principal of Nanotechnology in Clinical Research
Bera, K., Ghosh, B., & Mukhopadhyay, M. (2022) · Wiley eBooks · doi:10.1002/9781119857747.ch2 · Cited by 2
Gold Nanoparticles Stimulate the Maturation and Activation of Mouse Bone Marrow Dendritic Cells
Aluisa, A., Debut, A., Seqqat, R., & Arias, M. T. (2022) · International Journal on Advanced Science Engineering and Information Technology · doi:10.18517/ijaseit.12.6.17170 · Cited by 1
Recent process of using nanoparticles in the T cell-based immunometabolic therapy
Chen, B., Li, Y. Y., & Wang, H. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2024-0072 · Cited by 1
In situ released bacterial membrane vesicles activate the STING pathway via boosting the intracellular DNA pool for immunotherapy
Wang, W., Song, A., Pu, F., Zhang, Y., Ren, J., & Qu, X. (2025) · Chemical Science · doi:10.1039/d5sc07867a · Cited by 1
Enhanced Upconversion Luminescent Nanocarrier for Effective Tumor‐Targeted Photodynamic Therapy Combined with Immunotherapy
Choi, J., Yuh, H. S., Park, B. Y., & Kim, S. Y. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504598 · Cited by 1
Defective piezoelectric metal-organic frameworks elicit demethylation for enhanced cancer pyroptosis and immunotherapy
Guo, X., Yuan, C., Yang, Z., Xu, J., Li, P., Zhou, Q., Wang, X., Chen, L., & Tu, P. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.173285 · Cited by 1
Cancer-Immunity Cycle-Based Smart Nucleic Acid Nanodrugs for Potentiated Immunotherapy
Wu, B., Chen, J., Jiang, L., Zhao, Z., Shan, X., Ouyang, C., Jiang, P., Tong, X., Lü, Y., Zhang, J., et al. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00202 · Cited by 1
Ultrasound-driven nanotechnologies to overcome cancer immunotherapy resistance: From antigen presentation to metabolic rewiring
Zhang, B., Zhang, X., Yang, S., Sang, M., Sha, Y., Chen, G., Zhang, S., Hu, J., Gao, Y., Zhang, R., et al. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115691 · Cited by 1
An intelligent responsive nanoplatform based on a DNA nanoflowers/Mn:CuS hybrid for targeted and synergistic cancer therapy
Zhang, M., Wu, Y., Hu, L. I. N., Pei, D., Wang, J., & Yi, X. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02930a · Cited by 1
Harnessing veterinary nanomedicine: A One Health perspective
Cillari, R., & Mauro, N. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115139 · Cited by 1
Intra-arterial delivery of FePt nanoparticles induces ferroptosis and immune infiltration to enhance radiotherapy
Yeh, Y., Huang, Y., Shan, Y., Wu, S., Wang, H., Hou, P., Chang, Y., Su, W., Chen, H. H. W., Yen, C., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103461 · Cited by 1
Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures
Bogoyavlenskiy, A. P., Berezin, V., Alexyuk, M., Alexyuk, P., & Omirtaeva, E. S. (2026) · Molecules · doi:10.3390/molecules31142501 · Cited by 1
Biyoaktif Bileşiklerin Elektrospinning Yöntemi İle Nanoenkapsülasyonu
Çeliközlü, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1560 · Cited by 1
Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy
Shahreen, N., Agnihotri, A., Rizwan, A., Hasan, F., Ansari, M. D., Sofian, Z. M., Said, N. A. B. M., To, K. K. W., & Mahmood, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1643791 · Cited by 1
Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo‐Immunometabolic Therapy
Chota, A., Sarbadhikary, P., Abrahamse, H., & George, B. P. A. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70042 · Cited by 1
Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies
Cho, U., Pu, J., Sharma, A., Song, J., You, J. H., Kim, Y., Im, P. W., Park, H. W., Moon, H. E., Myeong, H. S., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02736-0 · Cited by 2
A thermodynamic model to predict the minimum energy required for engulfment of linearly aggregated spherical nanoparticles by tubular vesicles
Patil, U., & Ravikumar, C. (2022) · Materialia · doi:10.1016/j.mtla.2022.101663 · Cited by 1
Nanomaterials as Drug Carriers in Diagnosis and Treatment of Various Cancers
Ahalliya, R. M., Girisan, E. K., Gopalakrishnan, V. K., Meenakshi, P., & Kumar, D. G. (2022) · Materials horizons · doi:10.1007/978-981-19-2639-6_11 · Cited by 1
Transcriptional Targeting of Dendritic Cells Using an Optimized Human Fascin1 Gene Promoter
Zeyn, Y., Hobernik, D., Wilk, U., Pöhmerer, J., Hieber, C., Medina‐Montano, C., Röhrig, N., Strähle, C. F., Thoma‐Kress, A. K., Wagner, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316938 · Cited by 1
An Introduction to Recent Approaches Underlying Mechanistic Insights Harboring Oncobiology
Sobti, R. C., & Sobti, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_82 · Cited by 1
Application of Infrared Spectroscopy in the Field of Tumor
Chen, L., & Zhu, K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006704 · Cited by 1
TMEM173 is a biomarker of predicting prognosis, immune responses and therapeutic effect in human lung adenocarcinoma
Zhou, P., Wang, P., & Li, B. (2024) · Discover Oncology · doi:10.1007/s12672-024-01482-3 · Cited by 1
Peptide Antigen‐Surfaced TLR9‐Adjuvanting Nanovaccines as a Versatile Therapeutic Modality to Eradicate Acute Myeloid Leukemia
Sun, Y., Cui, G., Shi, Y., Xu, B., Qu, L., Meng, F., & Zhong, Z. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202416147 · Cited by 1
Glycan Covalent Targeting Chimera‐Based T‐Cell Glycoengineering for Boosting Immunotherapy
Wang, Y., Yan, X., Lu, D., Wang, H., Li, K., Chen, L., Wang, L., Cheng, S., Wang, G., Wang, R., et al. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202500364 · Cited by 1
Nanomedicine and Immunotherapy for Cancers
Navas, A. A., Doreswamy, N., & Francis, P. J. J. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.5.482 · Cited by 1
Biological Omics Analysis of Tumor Mutation Burden Combined with Immune Infiltrates in Uterine Corpus Endometrial CarcinomaPreprint
Zhuang, Y., Liu, C. X., Huang, J., & Li, G. (2020) · doi:10.21203/rs.3.rs-37252/v1 · Cited by 1
Editorial: Special issue on advances in nanomedicine
Zhang, Y., & Pei, R. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac8fc9 · Cited by 1
Nanomaterials in Cancer Therapy
Kanathasan, J. S., Nallappan, D., Poddar, S., & Ware, A. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-0448-8.ch008 · Cited by 1
A comprehensive study of the erosion mechanism of porous hybrid particles for biomedical applications
Christodoulou, I. (2021) · theses.fr (ABES) · doi:10.70675/e1570fbfza3c0z4fffza3f2z5d9f20b7cc25 · Cited by 1
Nanogel antigen DDS toward overcoming immune resistance of cancer
Harada, N., Muraoka, D., Shiku, H., & Akiyoshi, K. (2020) · Drug Delivery System · doi:10.2745/dds.35.64
SINGLE-WALLED CARBON NANOTUBES FOR ADVANCED OPTICAL MATERIALS, WEARABLE BIOSENSING, AND BIOIMAGING
Safaee, M. M. (2020) · doi:10.23860/safaee-mohammad-moein-2020
Photothermal Nanomaterials for Oncological Hyperthermia
You, M., Zhu, H., Li, Z., & Ye, E. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165177-00321
Study on the Changes and Correlation of Related Immune Factors before and after Chemotherapy in Non-Small Cell Lung Cancer
Zhang, J., Song, D., Dong, Y., Bai, L., Dongqi, G., Zhang, S., Guo, Y., Li, F., Yu, X., & Li, Q. (2022) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2022.131004
Experimental Animal Models to Evaluate the Therapeutic Efficacy of Nanoformulations Against Cancer
Narayan, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_133-1
Toxin and Immunotoxin Based Therapeutic Approaches
Bortolotti, M., Polito, L., & Bolognesi, A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3065-9
Nano-Biomaterials for Immunotherapy Applications
Saxena, P. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815051278122010004
Polymeric micelles as delivery systems for anticancer immunotherapy
Parayath, N. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00004-5
Introduction on Personalized Immune-Oncology
Abadi, B., & Rezaei, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_286-1
Smart bio-encapsulation for immunotherapy
Nasery, M. M., Abadi, B., Seyedpour, N., Bazdar, P., & Eslaminejad, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91229-7.00009-x
The Effects of Angiotensin-Converting Enzyme Inhibitors on Metastasis-Associated Myeloid Cells
Vallejo-Ardila, D. L., Parra-Medina, R. S., Cómbita, A. L., Cardona, A. F., & Paquet‐Fifield, S. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_91
ERO1α Promotes Tumorigenesis in EGFR Driven NSCLC
Johnson, B. D. (2022) · doi:10.33915/etd.11621
Facile fabrication of silk sericin-coated zeolitic imidazolate framework-8 nanocarriers encapsulating cabazitaxel for the treatment of liver cancer cells and their cell death mechanism
Xia, Q., Shen, J., & Li, X. (2023) · Journal of Materials Science · doi:10.1007/s10853-023-08605-1
Antibody-conjugating nanogel (Conjugel) with two immune checkpoint inhibitors for enhanced cancer immunotherapyPreprint
Chae, Y. J., Lee, K.-G., Oh, D., Lee, S., Park, Y., & Kim, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563185
Antibody-conjugating nanogel (Conjugel) with two immune checkpoint inhibitors for enhanced cancer immunotherapyPreprint
Kim, J., Park, Y., Chae, Y. J., Lee, K.-G., Oh, D., & Lee, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3468161/v1
Cancer-specific Nanomedicine Delivery Systems and the Role of the Tumor Microenvironment: A Critical Linkage
Chakraborty, D. D., & Chakraborty, P. (2023) · Current Nanomedicine · doi:10.2174/0124681873270736231024060618
An Introduction to Recent Approaches Underlying Mechanistic Insights Harboring Oncobiology
Sobti, R. C., & Sobti, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_82-1
Bilgisayar Destekli İlaç Tasarımı ve Tasarımın Ticari Ürün Örneklerine Kısa Bir Bakış
Karabulut, Y. K., & TURHAN, Z. Ş. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1553
Yeşil Sentez: Nano Partiküller ve Potansiyel Uygulama Alanları
Yiğit, A., Karakoyun, N., & TURHAN, Z. Ş. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1554
Nanotechnology and Current Applications in Biotechnology
Bozbeyoğlu, P., & Keçeci, P. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1559
Astım ve Lökotrien Reseptör Antagonistleri
Dilek, G. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1561
Nanoteknoloji ve Organik Kimya
Demirci, M. A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1558
Nanoteknoloji ve Organik Kimya
Yiğit, A., Karabulut, Y. K., Turhan, Z., Yiğit, A., Karakoyun, N., Yıldız, G., Kasımoğulları, R., Biçer, A., Demirel, N., Demirci, M. A., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393
Nanobiyoteknoloji ile Sürdürülebilir Bitki Sağlığı ve Çevre Yönetimi
Demirel, N. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1557
Recent Developments in Benzimidazole Derivatives (2023)
Yıldız, G., & Kasımoğulları, R. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1555
β-Sülfonil Ketonların Sentez Yöntemleri
Biçer, A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1556
Nanomaterials in theranostics
Gao, Z., & Ding, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95513-3.00011-3
Self‐assembling Bioactive Peptides for Supramolecular Cancer Immunotherapy
Li, S., Yan, X., & van Hest, J. C. M. (2024) · Wiley eBooks · doi:10.1002/9783527841264.ch22
Melanoma and nanotechnology-based treatment
Amor, A. B., Zeghoud, S., Hemmami, H., Alhamad, A. A., Gheraissa, N., & Amor, I. B. (2024) · International Journal of Surgery Global Health · doi:10.1097/gh9.0000000000000286
Cancer nanoimmunotherapy in the present scenario
Ancira-Cortez, A., Gibbens-Bandala, B., Cruz-Nova, P., Meléndez‐Alafort, L., & Ocampo‐García, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15518-5.00021-5
Generating specific homologous neutralizing-antibodies: a novel therapeutic strategy in cancer treatmentPreprint
Liu, Z. (2024) · eLife · doi:10.7554/elife.95678.1
Immunotherapy of breast cancer with folate targeted PLGA nanoparticles photothermal therapy combined with checkpoint CTLA4 blockingPreprint
HU, C., Ke, Q., Jiang, Y., Wu, Z., Chen, Y., Wu, Z., Zhang, Q., Wang, Y., & Wu, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4344438/v1
Delivery strategies of immunotherapies in the treatment of pancreatic cancer
Gupta, M. K., & Vadde, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23523-8.00004-3
Nanotechnology-enhanced immunotherapy for cancer
Naik, A. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13209-4.00001-5
Development of smart optical nanoagents for cancer immunotheranostics
Xu, C. (2024) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/179290
Custom made brachytherapy applicator for squamous cell carcinoma of oral commissures
Gupta, L., Mukherji, A., Pujari, L., Maknikar, V. P., Zaidi, A., & Kumar, A. (2024) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_434_24
Delivery strategies of immunotherapies in the treatment of colorectal cancer
Gupta, M. K., Tatireddigari, V. R. R. A., & Vadde, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24742-2.00007-1
Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers
Ahangarzadeh, S., Mohammadi, E., Yaghoobi, H., Shahzamani, K., Bahrami, A. A., Arezumand, R., Beikmohammadi, L., & Alibakhshi, A. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206369319250402150638
Harnessing Biomaterials to Overcome Challenges in Cancer Immunotherapy
Pazhamalai, V., Venkatesan, M., Rajkumar, J., Meenambiga, S. S., Romauld, S. I., Rajakumari, K., & Gowthami, V. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-1305-4.ch006
Mechanisms of the regulation of tumor cell death by metal ion-based nanomaterials
Yang, Y., Sun, S., Yang, N., Nie, J., & Cheng, L. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0118
NIR light-driven transformable liquid metal-based nanovaccines restrain postoperative colorectal cancer recurrence
Dai, Z., Liu, F., Liu, M., Song, Y., Zhang, H., Zhou, C., Liu, W., Li, X., Wang, G., Wang, L., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.06.037
NanoFLUID is a flexible bioelectronic delivery patch
Ye, R., Zhang, Y., & Qin, S. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101112
Research progress of psychological intervention assisted gold nanoparticles drug delivery in the treatment of triple-negative breast cancer patients
Zhao, Y., Cheng, Z., Zhang, C., Jiang, A., Shao, J., Ma, X., & Dong, X. (2025) · Psycho-Oncologie · doi:10.18282/po4477
Cancer immunotherapy
Bakhshi, P., Mohsenzadegan, M., & Farajollahi, M. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21521-6.00005-3
Introduction on Personalized Immune-Oncology
Abadi, B., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_286
Immunotherapy for Breast Cancer
Costa, K. M. N., de Melo, D. F., Soares, I. L. D. S., Damasceno, B. P. G. D. L., & Oshiro, J. A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_224
Application of gold nanoparticles in dentistry
Cherian, T., Varghese, N., Jacob, J., & Sadaka, M. C. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31392-9.00013-3
A battery-free, chipless, soft nanofluidic intracellular delivery patch for internal organsPreprint
Yu, C., Li, M., Chang, L., Yu, X., Yin, D., Wang, P., Hao, Y., Yue, W., Yao, K., Wang, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2154899/v1
Additional file 1 of Methylene blue associated with maghemite nanoparticles has antitumor activity in breast and ovarian carcinoma cell lines
Silva, A. L. G., de Carvalho, N. V., Paterno, L. G., de Moura, L. D., Filomeno, C. L., de Paula, E., & Báo, S. N. (2021) · Figshare · doi:10.6084/m9.figshare.14576379
Additional file 1 of Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
Wang, H., Wang, L., Li, Y., Li, G., Zhang, X., Jiang, D., Zhang, Y., Liu, L., Chu, Y., & Xu, G. (2021) · Figshare · doi:10.6084/m9.figshare.16435773
Additional file 1 of GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model
Dai, J., Li, J., Zhang, Y., Wen, Q., Lu, Y., Fan, Y., Zeng, F., Qian, Z., Zhang, Y., & Fu, S. (2023) · Figshare · doi:10.6084/m9.figshare.24425671
Additional file 2 of Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
Wang, H., Wang, L., Li, Y., Li, G., Zhang, X., Jiang, D., Zhang, Y., Liu, L., Chu, Y., & Xu, G. (2021) · Figshare · doi:10.6084/m9.figshare.16435776
Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment
Parés, M., Martínez-Latorre, J., Candela‐Noguera, V., Soriano‐Teruel, P. M., García‐Fernández, A., Pallaruelo-Santamaría, V., Aznar, E., Martínez‐Máñez, R., & Fillat, C. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118919

Authors: Goldberg, M. S.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Goldberg, Michael S.
ORCID: Goldberg, Michael S.
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2019-09-06
Volume: 19
Issue: 10
Pages: 587-602
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-019-0186-9
OpenAlex: W2972159813
Cited by: 628
References: 142
Citations by year: 2026: 44 · 2025: 67 · 2024: 81 · 2023: 98 · 2022: 114 · 2021: 122 · 2020: 92 · 2019: 10
FWCI: 8.06
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: cancer immunotherapy, nanotechnology, nanoparticles, biomaterials, drug delivery, immune evasion, spatiotemporal control, pharmacokinetics, co-delivery, adoptive immunotherapy, tumor targeting, nanomedicine
MeSH terms: Animals, Biocompatible Materials, Humans, Immune System, Immunologic Factors, Immunotherapy, Leukocytes, Neoplasms, Nucleic Acids, T-Lymphocytes, Drug Delivery Systems, Adoptive Transfer, Nanomedicine, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Improving cancer immunotherapy through nanotechnology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks